Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of JARFLOZIN vs Jardiance 25 mg in Healthy Thai Volunteers (Fasting)
TCTR20250401006Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of empagliflozin (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
empagliflozin
Beyond the preview
Go deeper on TCTR20250401006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250401006.